Reuters also highlighted that funding remains one of the sector’s biggest challenges as federal restrictions keep most banks and institutional investors out, forcing producers to rely on costly loans or alternative lenders.
CNBC reported that Tilray CEO Irwin Simon said, “I’m a lot more optimistic than I ever have been.”
Shawn Hauser, a partner at cannabis-focused law firm Vicente LLP, told CNBC that rescheduling would represent only a “partial victory,” as the sector will still need to fight for legalization.
She said the momentum can press Congress to build a regulatory framework that delivers broader changes around safety, access and criminal justice reform than rescheduling alone.
Hauser described this as “the beginning of a new era of public health policy” and said, “If implemented, it dismantles nearly a century of outdated drug policies that fly in the face of science and medicine,” according to CNBC.
